About this data
What it is
Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
Who files it
The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
How current
New filings are posted every day. We read each one the day after it is posted.
Terms
Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
Worth knowing
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.

All of this comes from lobbying disclosure filings that the Senate and the House publish.

Latest Capitol Hires

Reset
Capitol Hires
The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written.The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them.
BMRN
BioMarin Pharmaceutical Inc.
Brent del MonteBliley (House)
Member office · House
Leg. DirBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Brent del MonteCommerce Committee
Committee
Sen. Counsel House EnergyBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
John StoneOversight Subcommittee
Committee
CounselBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
John StoneHouse E&C Cmte
Committee
Senior CounselBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
John StoneHealth Subcommittee
Committee
Senior CounselBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
John StoneHouse Energy and Commerce
Committee
InternBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Daniel FarmerDebbie Wasserman Schultz
Member office · Democrat-FL
Intern, Staff Asst, Leg. Corr./Leg. AsstBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Daniel FarmerZack Space
Member office
Leg. Asst., Sr. Leg. Asst., Leg. DirBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyPanetta (House)
Member office · House
COSBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyAshford (House)
Member office · House
LDBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyMatheson (House)
Member office · House
LDBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyMatsui (House)
Member office · House
Sr. LABGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyBaron Hill (House)
Member office · House
LA, Sr. LABGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Joel BaileyRahall (House)
Member office · House
InternBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Remy MasonSenate HELP Committee
Committee
Senior FDA Policy Advisor to Ranking Member Patty MurrayBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Remy MasonElizabeth Warren
Member office · Democrat-MA
Senior Health Policy AdvisorBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
Remy MasonAllyson Y. Schwartz
Member office · Democrat-PA
InternBGR Government Affairs
Report period 2026 Q3 ↗
Posted Oct 20, 2026 · in 8 filings
BMRN
BioMarin Pharmaceutical Inc.
James WilliamsWH
Executive branch · 2017–2019
Economist, Council of Economic AdvisorsBGR Government Affairs
Report period 2026 Q2 ↗
Posted Jul 20, 2026 · in 3 filings
BMRN
BioMarin Pharmaceutical Inc.
Tim CareyBrad Sherman
Member office · Democrat-CA
Legislative DirectorVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Tim CareyAnna G. Eshoo
Member office · Democrat-CA
Deputy Legislative DirectorVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Elizabeth LeeServices Administration
Executive branch
Senior Policy Advisor to the Administrator of the Health ResourcesVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Elizabeth LeeTammy Baldwin
Member office · Democrat-WI
legislative aideVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Michael SpiraCarolyn McCarthy
Member office · Democrat-NY
Chief of Staff for formerVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Michael SpiraEd Perlmutter
Member office · Democrat-CO
Deputy Chief of StaffVenn Strategies
Report period 2017 Q2 ↗
Posted Jul 6, 2026
BMRN
BioMarin Pharmaceutical Inc.
Alanna TemmeJon Porter (House)
Member office · House
Legislative DirectorLMH Strategic Solutions
Report period 2025 Q4 ↗
Posted Apr 17, 2026 · in 6 filings
BMRN
BioMarin Pharmaceutical Inc.
Robb WaltonSenate HELP
Committee
Senior Health Policy Advisor and CounselBGR Government Affairs
Report period 2025 Q3 ↗
Posted Oct 20, 2025 · in 4 filings
BMRN
BioMarin Pharmaceutical Inc.
Robb WaltonCassidy (House)
Member office · House
; AdvisorBGR Government Affairs
Report period 2025 Q3 ↗
Posted Oct 20, 2025 · in 4 filings
BMRN
BioMarin Pharmaceutical Inc.
Robb WaltonEnzi (Senate)
Member office · Senate
; Research Asst., Staff Asst., Intern on , Ranking MemberBGR Government Affairs
Report period 2025 Q3 ↗
Posted Oct 20, 2025 · in 4 filings
BMRN
BioMarin Pharmaceutical Inc.
Robb WaltonNunes (House)
Member office · House
InternBGR Government Affairs
Report period 2025 Q3 ↗
Posted Oct 20, 2025 · in 4 filings
BMRN
BioMarin Pharmaceutical Inc.
Joshua OdintzSenate Finance Committee
Committee
Tax CounselHolland & Knight LLP
Report period 2024 Q4 ↗
Posted Nov 12, 2024

The newest 30 of 30 matching. Narrow them with the filters above.

Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 5:46 PM EST.